4//SEC Filing
Walker Marlan D 4
Accession 0000905148-25-001190
CIK 0000025743other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:29 PM ET
Size
6.3 KB
Accession
0000905148-25-001190
Insider Transaction Report
Form 4
Walker Marlan D
Chief Executive Officer
Transactions
- Purchase
Common Stock
2025-04-10$0.86/sh+1,167$1,000→ 73,149 total - Purchase
Common Stock
2025-04-09$0.87/sh+1,136$994→ 71,982 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $0.8741 through $0.88, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001820187
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 4:29 PM ET
- Size
- 6.3 KB